FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:2062-2068 June 27, 2002 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Atrial fibrillation is a common arrhythmia that causes symptoms such as palpitations and dyspnea but is also associated with stroke, heart failure, and an increased risk of hospitalization and death.^1,2 The incidence of atrial fibrillation increases markedly with age. As the average age of the general population increases, the overall prevalence of atrial fibrillation is also increasing. Among the most common approaches to management are rate control plus anticoagulation and rhythm control with antiarrhythmic medications. Neither of these two strategies is ideal. Anticoagulation does not eliminate the risk of stroke, and the antiarrhythmic drugs often do not maintain sinus rhythm.^3,4 . . . [Full Text of this Article]

Ventricular Pacing during Atrial Fibrillation

Prevention of Atrial Fibrillation with Atrial Pacing

Alternative-Site and Dual-Site Atrial Pacing

Overdrive Atrial Pacing

High-Frequency Pacing and Electrical Cardioversion

Conclusions

Source Information

From the Cardiovascular Division, Brigham and Women's Hospital, Boston (J.M.C.); and Division of Cardiology, Veterans Affairs Boston Healthcare System, Veterans Affairs Medical Center, West Roxbury, Mass. (M.S.K., M.V.O.).

Address reprint requests to Dr. Katcher at Cardiology 111A, VA Boston Healthcare System, 1400 VFW Pkwy., West Roxbury, MA 02132.

This article has been cited by other articles:

• Van Gelder, I. C., Hemels, M. E.W. (2006). The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm. Europace 8: 943-949 [Abstract] [Full Text]  
• Hemels, M. E.W., Gu, Y. L., Tuinenburg, A. E., Boonstra, P. W., Wiesfeld, A. C.P., van den Berg, M. P., Van Veldhuisen, D. J., Van Gelder, I. C. (2006). Favorable long-term outcome of maze surgery in patients with lone atrial fibrillation.. Ann. Thorac. Surg. 81: 1773-1779 [Abstract] [Full Text]  
• Goldberger, Z., Lampert, R. (2006). Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies. JAMA 295: 809-818 [Abstract] [Full Text]  
• Hemels, M. E.W., Wiesfeld, A. C.P., Inberg, B., Van Dessel, P. F.H.M., Nieuwland, W., Tan, E. S., Mulder, H., Van Veldhuisen, D. J., Van Gelder, I. C. (2006). Right atrial overdrive pacing for prevention of symptomatic refractory atrial fibrillation.. Europace 8: 107-112 [Abstract] [Full Text]  
• Doi, A., Takagi, M., Toda, I., Yoshiyama, M., Takeuchi, K., Yoshikawa, J. (2005). Acute Hemodynamic Benefits of Bi-Atrial Atrioventricular Sequential Pacing With the Optimal Atrioventricular Delay. J Am Coll Cardiol 46: 320-326 [Abstract] [Full Text]  
• Boriani, G., Maron, B. J., Shen, W.-K., Spirito, P. (2004). Prevention of Sudden Death in Hypertrophic Cardiomyopathy: But Which Defibrillator for Which Patient?. Circulation 110: e438-e442 [Full Text]  
• Doi, A, Takagi, M, Toda, I, Yoshiyama, M, Takeuchi, K, Yoshikawa, J (2004). Acute haemodynamic benefits of biatrial atrioventricular sequential pacing: comparison with single atrial atrioventricular sequential pacing. Heart 90: 411-418 [Abstract] [Full Text]  
• Wattigney, W. A., Mensah, G. A., Croft, J. B. (2003). Increasing Trends in Hospitalization for Atrial Fibrillation in the United States, 1985 Through 1999: Implications for Primary Prevention. Circulation 108: 711-716 [Abstract] [Full Text]